ENVB - Multiplikator Forward P/S Enveric Biosciences, Inc.

Enveric Biosciences (ENVB) is currently in the early research stage of psychopharmacology without active profit generators. Geopolitical fragmentation limits the export of psychedelics and hinders global research. However, streamlined cross-border raw material logistics ensure high margins. The projected P/S metric reflects market revenue expectations, with the latest value recorded as .

ENVB enveric.com: Rega forward marang dodolan ing interval 04.07.2022 - 13.11.2026

Ringkesan rincian data analitis Enveric Corp (ENVB)

- rega saham lan target rega konsensus:

Kutipan saham Enveric Biosciences, Inc.|ENVB - Bagan rega target

- statistik kapitalisasi pasar:

Kapitalisasi pasar Enveric Corp|ENVB - Total Nilai Perusahaan

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham Enveric Biosciences|ENVB - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku enveric.com|ENVB - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Enveric Biosciences|ENVB - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Enveric Biosciences|ENVB - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Enveric Corp|ENVB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Enveric Biosciences|Likuiditas cepet enveric.com

- data bathi bisnis lan rasio investasi:

ENVB - Penghasilan resik perusahaan|Bathi sing dikarepake Enveric Biosciences|ENVB - Periode bali modal bisnis|Pangali Forward P/E Enveric|ENVB - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Enveric Corp|ENVB - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Enveric Biosciences|ENVB - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan enveric.com|ENVB - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Enveric Biosciences

- statistik dodolan lan pendapatan perusahaan:

ENVB - Dodolan perusahaan|Prakiraan volume dodolan Enveric Biosciences, Inc.|ENVB - Rega marang dodolan|Rasio rega marang prakiraan pendapatan Enveric Corp

Ringkesan analisis perusahaan:Enveric Biosciences, Inc. ENVB

The forward P/S reflects market expectations regarding business value by comparing current capitalization with projected sales volume. Analyzing the forward P/S valuation at , an investor sees a premium for future growth, which for the non-cyclical biotech Enveric Biosciences (ENVB) depends not on macroeconomics, but on the volume of available cash and the success of clinical trials.

Karo sapa Enveric Biosciences saingan

Indivior - Multiplikator forward rega marang pendapatan|Collegium Pharma - Rasio rega marang prakiraan pendapatan|Cronos - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Canopy Growth Corp.|High Tide Inc. (HITI) - Rasio rega marang prakiraan pendapatan|Aurora Cannabis Inc. - Rega forward marang dodolan|ACHV (Achieve Life Sciences, Inc.) - Multiplikator Forward P/S|Skye Bioscience Inc. (SKYE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ANEB|Multiplikator forward rega marang pendapatan intercure.co INCR|Nutriband - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NSRX|IGC Pharma Inc - Multiplikator Forward P/S|MIRA: Rasio rega marang prakiraan pendapatan|FLGC: Multiplikator Forward P/S|IMCC - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adial Pharmaceuticals Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Artelo ARTL|Rasio rega marang prakiraan pendapatan Ensysce Biosciences (ENSC)|Rasio kapitalisasi marang dodolan sing dikarepake titanpharm.com|Multiplikator Forward P/S GNLN (Greenlane Holdings Inc)|INM - Multiplikator forward rega marang pendapatan|Akanda - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Bright Green BGXX|HPCO: Multiplikator Forward P/S